Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9(R) lead to promotion versus suppression of prostate cancer metastasis [Additions and Corrections]

VOLUME 288 (2013) PAGES 19359–19369For Fig. 5E, in the last row stained for PSA, one of the images in the MDV group was mistakenly inserted as the ASC group with a vertical translation during article preparation. The correct images from the MDV group and ASC group are presented in the corrected figure. We sincerely apologize for the error, and we assure that the correction of the images will not alter the original results or conclusions.jbc;295/46/15796/F5F1F5Figure 5E.

Source: Journal of Biological Chemistry - November 13, 2020 Category: Chemistry Authors: Tzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, Defeng Xu, Liang Liang, Lei Li, Shauh-Der Yeh, Naohiro Fujimoto, Shuyuan Yeh, Chawnshang Chang Tags: Additions and Corrections Source Type: research